← Back to Patent Explorer
US5041580A Expired / Lapsed US ⏱️ 0.0 years remaining

Novel binuclear platinum complex and antitumor agent comprising this complex as active ingredient

Assignee: Tsumura and Co
•
Filing: 1989-12-28
•
Granted: 1991-08-20
•
Expires: 2009-12-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed are a binuclear platinum complex including di-μ-sulfoacetato-bis[1,2-diaminocyclohexane-platinum (II)] and isomers thereof, and an antitumor agent comprising this complex as an effective ingredient. This complex has a high antitumor activity and lower adverse side effects such as nephrotoxicity.

Inventors

  • 👤 Ken Miyamoto
  • 👤 Yuichi Fujii

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 19:32
CPC Classifications
C; C07; C07F; C07F15/00; C07F15/0006; C07F15/0086; C07F15/0093; A; A61; A61P; A61P35/00

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 11 words
A binuclear platinum complex represented by the following formula I: ##STR2##
Claim 2
Dependent Claim 11 words
A binuclear platinum complex represented by the following formula I: ##STR2##
Claim 3
Dependent Claim 11 words
A binuclear platinum complex represented by the following formula II. ##STR3##
Claim 4
Dependent Claim 11 words
A binuclear platinum complex represented by the following formula II. ##STR3##
Claim 5
Dependent Claim 11 words
A binuclear platinum complex represented by the following formula III: ##STR4##
Claim 6
Dependent Claim 11 words
A binuclear platinum complex represented by the following formula III: ##STR4##
Claim 7
Dependent Claim 2 words
Di-μ-sulfoacetato-bis[(cis-diaminocyclohexane)platinum (II)].
Claim 8
Dependent Claim 2 words
Di-μ-sulfoacetato-bis[(cis-diaminocyclohexane)platinum (II)].
Claim 9
Dependent Claim 18 words
An antitumor agent comprising as an effective ingredient a binuclear platinum complex represented by the following formula: ##STR5##
Claim 10
Dependent Claim 18 words
An antitumor agent comprising as an effective ingredient a binuclear platinum complex represented by the following formula: ##STR5##
Claim 11
Dependent Claim 18 words
An antitumor agent comprising as an effective ingredient a binuclear platinum complex represented by the following formula: ##STR6##
Claim 12
Dependent Claim 18 words
An antitumor agent comprising as an effective ingredient a binuclear platinum complex represented by the following formula: ##STR6##
Claim 13
Dependent Claim 18 words
An antitumor agent comprising as an effective ingredient a binuclear platinum complex represented by the following formula: ##STR7##
Claim 14
Dependent Claim 18 words
An antitumor agent comprising as an effective ingredient a binuclear platinum complex represented by the following formula: ##STR7##
Claim 15
Dependent Claim 10 words
An antitumor agent comprising di-μ-sulfoacetato-bis-[(cis-diaminocyclohexane)platinum (II)] as an effective ingredient.
Claim 16
Dependent Claim 10 words
An antitumor agent comprising di-μ-sulfoacetato-bis-[(cis-diaminocyclohexane)platinum (II)] as an effective ingredient.

References Cited (Backward Citations)

US4560782A Cited
US4533502A Cited
US4565884A Cited
US4730069A Cited
US4797393A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-08-19 1995-02-18 1995-08-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-08-19 1999-02-18 1999-08-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-08-19 2003-02-18 2003-08-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag